“…[9][10][11] Until now, nanostructuration of QCM-D sensor surfaces has been focused on creating 3D porous structures such as anodic aluminium oxide or inverse opals, showing promising results in improving analytical response against different targets, such as enzymes, liposomes, and antibodies. [12][13][14][15] However, those nanofabrication methodologies are limited in providing access to tailored, reproducible, and precisely controlled structures, preventing full exploitation for clinical applications. Moreover, the use of porous thin films can lead to solvent and artefact entrapment effects in the nanostructured film, hindering data interpretation and introducing uncertainty over obtained results.…”